Disease: Advanced Melanoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4727838
Disease: Advanced Melanoma
Advanced Melanoma 		0.010 Biomarker disease BEFREE Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. 22048237 2012